Keratinocyte Cancer Risk and Porokeratosis Mevalonate Pathway Variants
JAMA Dermatology · 01.08.2026 · 162 (8) · 851
DOI: 10.1001/jamadermatol.2026.1765 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.08.2026. Verfasst von William Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Yale School of Medicine, New Haven, Connecticut. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This cohort study evaluates the association of genetically diagnosed porokeratosis and skin cancer.
Autor:innen und Institutionen
- Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
- Boston University, Boston, Massachusetts.
- Department of Genetics, Yale School of Medicine, New Haven, Connecticut.
- Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
Zitieren
APA
Liu, W., Luo, A. J., Liu, W., Cohen, J., Choate, K. A., & Atzmony, L. (2026). Keratinocyte Cancer Risk and Porokeratosis Mevalonate Pathway Variants. JAMA Dermatology, 162(8), 851. https://doi.org/10.1001/jamadermatol.2026.1765
Vancouver
Liu W, Luo AJ, Liu W, Cohen J, Choate KA, Atzmony L. Keratinocyte Cancer Risk and Porokeratosis Mevalonate Pathway Variants. JAMA Dermatology. 2026;162(8):851. doi:10.1001/jamadermatol.2026.1765
BibTeX
@article{Liu2026,
author = {Liu, William and Luo, Angela J and Liu, Winston and Cohen, Jeffrey and Choate, Keith A and Atzmony, Lihi},
title = {Keratinocyte Cancer Risk and Porokeratosis Mevalonate Pathway Variants},
journal = {JAMA Dermatology},
year = {2026},
volume = {162},
number = {8},
pages = {851},
doi = {10.1001/jamadermatol.2026.1765}
}
EUVIMED